Larue William R Insider Trades

Insider Trading History

Track insider trading activity for Larue William R. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Director
Holding Value $1.16k 2,200 shares
Last Trade
Jun 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.8k 2,200 shares
$8.10
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Director
Holding Value $13.2k 25,000 shares
Last Trade
Jun 28, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$178k 25,000 shares
$7.11
$0.53
TRACON Pharmaceuticals
TRACON Pharmaceuticals TCON
Director
Holding Value $580 18,000 shares
Last Trade
Apr 19, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$655k 18,000 shares
$36.40
$0.03
TRACON Pharmaceuticals
TRACON Pharmaceuticals TCON
Director
Holding Value $250 7,763 shares
Last Trade
Dec 21, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.1k 120 shares
$25.80
$0.03
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Director
Holding Value $13.2k 25,000 shares
Last Trade
Jun 16, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$540k 25,000 shares
$21.60
$0.53
TRACON Pharmaceuticals
TRACON Pharmaceuticals TCON
Director
Holding Value $507 15,750 shares
Last Trade
Jun 14, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$410k 15,750 shares
$26.00
$0.03
TRACON Pharmaceuticals
TRACON Pharmaceuticals TCON
Director
Holding Value $254 7,883 shares
Last Trade
Jul 26, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$25k 6,545 shares
$3.82
$0.03
TRACON Pharmaceuticals
TRACON Pharmaceuticals TCON
Director
Holding Value $338 10,500 shares
Last Trade
Jun 10, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$68.8k 10,500 shares
$6.55
$0.03
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Director
Holding Value $13.2k 25,000 shares
Last Trade
May 25, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.57M 25,000 shares
$102.80
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Director
Holding Value $7.9k 15,000 shares
Last Trade
Jun 11, 2020 Sale (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$882k 15,000 shares
$58.80
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Director
Holding Value $7.9k 15,000 shares
Last Trade
Jun 11, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$882k 15,000 shares
$58.80
$0.53
TRACON Pharmaceuticals
TRACON Pharmaceuticals TCON
Director
Holding Value $145 4,500 shares
Last Trade
Jun 10, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.32k 4,500 shares
$2.07
$0.03
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Director
Holding Value $15.8k 30,000 shares
Last Trade
Sep 12, 2019 Sale (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.46M 30,000 shares
$115.20
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Director
Holding Value $15.8k 30,000 shares
Last Trade
Sep 12, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.46M 30,000 shares
$115.20
$0.53
Conatus Pharmaceuticals
Conatus Pharmaceuticals CNAT
Director
Holding Value $0 20,000 shares
Last Trade
Jun 27, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.00
Histogen
Histogen HSTO
Director
Holding Value $400 20,000 shares
Last Trade
Jun 27, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$57.9k 20,000 shares
$2.90
$0.02
TRACON Pharmaceuticals
TRACON Pharmaceuticals TCON
Director
Holding Value $483 15,000 shares
Last Trade
Jun 13, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.6k 15,000 shares
$0.64
$0.03
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Director
Holding Value $148 281 shares
Last Trade
Jun 07, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.36k 281 shares
$8.40
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Director
Holding Value $5.28k 10,030 shares
Last Trade
Jun 07, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$84.3k 10,030 shares
$8.40
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Director
Holding Value $8.5k 16,144 shares
Last Trade
Jun 07, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$136k 16,144 shares
$8.40
$0.53

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up